Hindustan Antibiotics


Hindustan Antibiotics Limited is an Indian central public sector undertaking under the ownership of Ministry of Chemicals and Fertilizers, Government of India. It is based in Pune, India. It is the first government-owned-drug manufacturer in India. It was the first to launch a recombinant DNA product, rHU-Erythropoietin in 1993.
It introduced new products like Halpen, Haltax, Hexpan in 2008. Sati-HIV drugs will be produced from September 2009.
WWW hindantibiotics.gov.in

History

HAtL was set up in cooperation with the WHO and UNICEF with the social objective of providing affordable drugs throughout India. It was inaugurated by India's first Prime Minister Jawaharlal Nehru on 10 March 1954. Production began in 1955. It was based on Mahatma Gandhi's vision that the poor in India should get medicines at affordable rates.
After reporting an operating loss in 1997 the company was reported to the Bureau of Industrial and Financial Restructuring. On 17 January 2009 the company was taken off the books of the BIFR after reporting a record turnover of ₹ 120 crore.

Operations

Although the company's primary objective was to develop drugs for the health-care industry, the company has now diversified into the agricultural and veterinary areas as well. The manufacturing plant located in Pimpri has facilities to produce bulk drugs as well as formulations in various dosage forms – injectables, capsules, tablets, large volume parentrals, liquid orals, etc.

In-house developed products

Health care

Agricultural and veterinary

  • Aureofungin
  • Humaur
  • Streptocycline
  • Azotomeal
  • Phosphomeal